*/ html { font-size:14px; } body { color:#222222; line-height:1.2; font-family: 'Lato', sans-serif; font-weight:400; } b, strong { font-weight:900; } a:link, a:visited, a:focus { color:#005AA4; text-decoration:underline; } a:hover { color:#005AA4; } h1 { color:#222222; font-size:2rem; font-weight:700; margin:0px 0px 10px 0px; } h2 { color:#222222; font-size:1.5rem; font-weight:700; margin:0px 0px 10px 0px; } h3 { color:#222222; font-size:1.3rem; font-weight:700; margin:0px 0px 10px 0px; } h3 a { text-decoration:none !important; } .small-header h3 { font-size:1.1rem; } h4 { color:#222222; font-size:1rem; font-weight:700; } h5 { color:#222222; font-size:1rem; } h6 { color:#222222; font-size:.9rem; } hr { border:0px; border-top:1px solid #d4d4d4; margin:15px auto; clear:both; } .title { padding:0px 0px 20px 0px; border-bottom:1px solid #d4d4d4; margin:0px 0px 20px 0px; } .primary-button a { color:#ffffff !important; background:#D3212F; padding:7px 15px; border-radius:5px; box-shadow: 0 2px 5px 0 rgba(0,0,0,0.16),0 2px 10px 0 rgba(0,0,0,0.12); margin:10px auto; display:inline-block; text-decoration:none !important; } .secondary-button a { color:#ffffff !important; background:#E4AA17; padding:7px 15px; border-radius:5px; box-shadow: 0 2px 5px 0 rgba(0,0,0,0.16),0 2px 10px 0 rgba(0,0,0,0.12); margin:10px auto; display:inline-block; text-decoration:none !important; } .accent-button a { color:#ffffff !important; background:#005AA4; padding:7px 15px; border-radius:5px; box-shadow: 0 2px 5px 0 rgba(0,0,0,0.16),0 2px 10px 0 rgba(0,0,0,0.12); margin:10px auto; display:inline-block; text-decoration:none !important; } .primary-button a::after, .secondary-button a::after, .accent-button a::after { font-family:"Font Awesome 5 Pro"; font-weight:900; content:"\f330"; padding:0px 0px 0px 30px; font-size:.8rem; } .responsive-table { width:100% !important; border:0px solid #d4d4d4; } .responsive-table tr td { padding:10px; border:1px solid #d4d4d4; } .committee-table.responsive-table tr td { padding:20px; border:1px solid #d4d4d4; } .committee-table.responsive-table .responsive-table tr td { padding:0px; border:1px solid #ffffff; } .empty-cell { border:0px solid #d4d4d4 !important; } .responsive-table tr td .title { padding:0px 0px 10px 0px; border-bottom:1px dashed #d4d4d4; margin:0px 0px 10px 0px; } .primary-cell { color:#ffffff !important; background:#D3212F; padding:10px; font-weight:bold; font-size:20px; } .secondary-cell { color:#ffffff !important; background:#E4AA17; padding:10px; font-weight:bold; font-size:20px; } .accent-cell { color:#ffffff !important; background:#005AA4; padding:10px; font-weight:bold; font-size:20px; } /* XS/SM ONLY ---------------------------------------------- */ @media (max-width: 767px) { .responsive-table tr td { float:left; width:100% !important; height:auto !important; } } /* GENERAL MD ------------------------------------------------- */ @media (min-width: 768px) { html { font-size:13px; } } /* GENERAL LG ------------------------------------------------- */ @media (min-width: 992px) { html { font-size:14px; } } /* GENERAL XL ------------------------------------------------- */ @media (min-width: 1200px) { html { font-size:16px; } }
like us on facebook connect with us on linkedin follow us on twitter September 01, 2021

Capture

To learn more about LUMAKRAS, click here

Section Header Section Header

Save The Date - MSHO 12th Annual Payer Update!

Live Event November 10, 2021 - Schoolcraft College, Livonia

Details >
Section Header Section Header

WPS Oncology Related LCD Updates

September 2021

Updates that may be of interest to oncology including:
• MolDX: Molecular Diagnostic Tests

Details >

WPS Recent Oncology Related News

Part A, Part B and Part A/B News

Includes articles that may be of interest to oncology released in the past 2 weeks
• Also, Medicare Hot Links to 2022 Proposed Rules, 2021 Final Rules and the WPS Fee Schedules

Details >

Join WPS for a Teleconference, Webinar or Seminar

Check out these upcoming training events:

• Teleconference: ABN: What’s New and What’s Not
• On Demand Training: Appeals - Understanding the Basics
• E & M Services for 2021
• 3 day/1 Day Payment Window
• New YouTube Training Available

Details >
Section Header

CMS-Medicare

Recent Oncology Related Articles

• Impact of the PHE on Telehealth: Comparative Billing Report in August
• CMS Resumes Targeted Probe & Educate Program
• Clinical Diagnostic Laboratories: Private Payor Rate-Based CLFS Resources
• Recent LearnResource & MedLearn Matters Articles

Details >

Michigan RAC Information

Region 1 - Performant Recovery, Inc.

MSHO NOTE: Many MSHO members have reported recent RAC audits related to waste and single dose vials! - MSHO working with the RAC to bring our members education - Be sure to click the details button below and read our 8/30/21 update!

Also, newest approved issues listed on RAC website:
• Positron Emission Tomography for Initial Treatment Strategy in Oncologic Conditions
• Next Generation Sequencing Medical Necessity and Documentation Requirements

Details >

Recent RAC Monitor Article

This edition includes an article on:

• More Money for CMS Means More Medicare Audits

Details >
Section Header

BCBSM/BCN

Recent Oncology Related News

• Internet Claim Tool taxonomy code edit error
• How to submit prior authorization requests for drugs that are managed by AIM when the drugs are prescribed for non-oncology diagnoses
• We’re updating our policy for non-chemotherapy drug administration coding
• Register today for the September PGIP quarterly meeting — in Lansing, Michigan
• Audit vendor HMS is launching an updated provider portal
• Four additional drugs to require prior authorization for Blue Cross URMBT non-Medicare members, for dates of service on or after Sept. 7
• RybrevantTM requires prior authorization for dates of service on or after Sept. 27 for most members
• Payment for certain drugs administered by health care provider changing in October
• Additional drugs require prior authorization for Blue Cross URMBT non-Medicare members, starting Nov. 1
• AsparlasTM to require prior authorization for Blue Cross URMBT non-Medicare members, starting Nov. 1

Details >

BCBSM/BCN

Publications

• The Record
• BCN Provider News
• Just Released - Blues Brief for Oncology Providers

Details >

Medicare Plus Blue

Monthly Status Report

Many updates/corrections. Listed below is a sampling of what you will find:
• 835 Recoupment isn't reflected on voucher
• 835 CARC 210 sanction amount is incorrect
• The system is applying a denied authorization to a claim in error
• Multiple RHC Issues

Details >
Section Header

Payer Issue Tracking Page

Last Reviewed/Updated 8/31/21

Review the reported payer reimbursement issues including:
• MPB diagnosis loading for biosimilars to match brand drugs, claims being reprocessed
• Confusion and clarification non-oncology Colony Stimulating Factor prior authorization

Details >

Medicaid

Recent Oncology Related News

Medicaid Updates Include:
• MSA Bulletin Updates
• Biller "B" Aware Notices

Details >

Newsletters of Interest

• Aetna OfficeLink Updates
• Cigna
• HAP
• Humana YourPractice
• UHC Network Bulletin
• UHC Medical Policy Update
• UHC Reimbursement Policy Update

Details >

Priority Health Update

• Prism Launches this September
• A Member Programs Catalog Now Available
• New preferred products for Medicare Part B drugs start Oct. 14 (Includes Erythropoietin stimulating agents)

Details >

Managed Care Committee Reimbursement TIDBITS

Featuring this month: HAP

Tidbits regarding:
• Easier Access to the Provider Portal Coming Soon!
• Billing Guidelines for COVID-19 Were Updated August 20
• Important Contact Information for Providers

Details >
Section Header Section Header Section Header

ASK MSHO

September 2021, Frequently Asked Questions

• NPP Billing for Genetic Counseling
• Billing and Infusion as a Push
• Utilize the Smallest Available Vial
• Billing for "Chemo Teach"

MSHO MEMBERS - You can access and search previous FAQs! Scroll to the bottom of the Q & As to find out how!

Details >